Semaglutide 14 mg Tablets are an oral semaglutide presentation in the GLP-1 receptor agonist class. In the FDA-approved Rybelsus 3 mg / 7 mg / 14 mg regimen, 14 mg is the higher maintenance strength that may be used when additional glycemic control is needed after treatment at 7 mg. Use only under prescription guidance and verify the exact product identity before making brand or generic-equivalence claims.Product at a Glance